MedElevator Войти в исследования
← Поиск публикаций

DOI 10.12998/wjcc.v10.i20.7124

Медицинская библиотека · World journal of clinical cases · 2022

Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report.

Agrawal Rohit, Guzman Grace, Karimi Saman, Giulianotti Pier Cristoforo, Lora Alfredo Jose Mena, Jain Shikha, Khan Meshaal, Boulay Brian R, Chen Yolande

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Immune checkpoint inhibitors have significantly improved survivals for an increasing range of malignancies but at the cost of several immune-related adverse events, the management of which can be challenging due to its mimicry of other autoimmune related disorders such as immunoglobulin G4 (IgG4) related disease when the pancreaticobiliary system is affected. Nivolumab, an IgG4 monoclonal antibody, has been associated with cholangitis and pancreatitis, however its association with IgG4 related disease has not been reported to date.

CASE SUMMARY: We present a case of immune-related pancreatitis and cholangiopathy in a patient who completed treatment with nivolumab for anal squamous cell carcinoma. Patients IgG4 levels was normal on presentation. She responded to steroids but due to concerns for malignant biliary stricture, she opted for surgery, the pathology of which suggested IgG4 related disease.

CONCLUSION

We hypothesize this case of IgG4 related cholangitis and pancreatitis was likely triggered by nivolumab.

Для цитирования: Agrawal Rohit, Guzman Grace, Karimi Saman, Giulianotti Pier Cristoforo, Lora Alfredo Jose Mena, Jain Shikha, Khan Meshaal, Boulay Brian R, Chen Yolande. Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report.. World journal of clinical cases. 2022. DOI: 10.12998/wjcc.v10.i20.7124.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.